Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

GEVELOT S.A.: Number of Shares and Voting rights 19 June 2023
GEVELOT S.A.: Number of Shares and Voting rights 19 June 2023
GEVELOT S.A.: Number of Shares and Voting rights 19 June 2023
GEVELOT S.A.: PRESS RELEASE - BOARD OF DIRECTORS JUNE 19, 2023
GEVELOT S.A.: PRESS RELEASE - BOARD OF DIRECTORS JUNE 19, 2023
GEVELOT S.A.: PRESS RELEASE - BOARD OF DIRECTORS JUNE 19, 2023
Dassault Aviation and Dassault Systèmes Partner to Bring Secure, Sovereign Collaboration on the Cloud to Next Generation Defense Programs: https://mms.businesswire.com/media/20191104005004/en/734381/5/3DS_Corp_Logotype_Blue_RGB.jpg
Dassault Aviation and Dassault Systèmes Partner to Bring Secure, Sovereign Collaboration on the Cloud to Next Generation Defense Programs


Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) and Dassault Aviation (Euronext Paris FR0014004L86, AM.PA) today announced at the Paris Air Show, the next step in their long-term

Teleperformance Appoints Bhupender Singh as Deputy Chief Executive Officer: https://mms.businesswire.com/media/20191104005672/en/676465/5/logo_-_new.jpg
Teleperformance Appoints Bhupender Singh as Deputy Chief Executive Officer


Regulatory News:



Teleperformance (Paris:TEP), a global leader in digital business services, today announced that its Board of Directors has appointed Bhupender Singh as Deputy Chief Executive

Sensorion Reports Promising Preliminary Data from SENS-401 Phase 2a Clinical Study: https://mms.businesswire.com/media/20210609005851/en/705797/5/logo-sensorion2.jpg
Sensorion Reports Promising Preliminary Data from SENS-401 Phase 2a Clinical Study


Regulatory News:



Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within

Sartorius Stedim Biotech lowers forecast for 2023
Sartorius Stedim Biotech lowers forecast for 2023
Sartorius Stedim Biotech lowers forecast for 2023
RALLYE S.A.: Agreement with all Rallye’s creditors benefiting from a trust (fiducie-sûreté) on Casino’s securities
RALLYE S.A.: Agreement with all Rallye’s creditors benefiting from a trust (fiducie-sûreté) on Casino’s securities
RALLYE S.A.: Agreement with all Rallye’s creditors benefiting from a trust (fiducie-sûreté) on Casino’s securities
EQS-News: Abivax receives “Capital Market Transaction of the Year Award” at the European Mediscience Awards 2023
EQS-News: Abivax receives “Capital Market Transaction of the Year Award” at the European Mediscience Awards 2023
EQS-News: Abivax receives “Capital Market Transaction of the Year Award” at the European Mediscience Awards 2023
Eutelsat to Dispose of Its European Retail Broadband Distribution Activities: https://mms.businesswire.com/media/20191112005524/en/397236/5/Eutelsat_Communications_logo.jpg
Eutelsat to Dispose of Its European Retail Broadband Distribution Activities


Regulatory News:



Eutelsat Communications (Euronext Paris: ETL) has reached an agreement to sell its European broadband retail activities to an experienced private operator. The activities to be

GEVELOT S.A.: PRESS RELEASE ANNUAL GENERAL MEETING 15 JUNE 2023
GEVELOT S.A.: PRESS RELEASE ANNUAL GENERAL MEETING 15 JUNE 2023
GEVELOT S.A.: PRESS RELEASE ANNUAL GENERAL MEETING 15 JUNE 2023
Jindal Stainless Selects Dassault Systèmes’ Solutions to Boost Operational and Delivery Efficiencies: https://mms.businesswire.com/media/20191104005004/en/734381/5/3DS_Corp_Logotype_Blue_RGB.jpg
Jindal Stainless Selects Dassault Systèmes’ Solutions to Boost Operational and Delivery Efficiencies


Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced that Jindal Stainless Limited (JSL), the leading stainless steel manufacturer in India, will deploy Dassault Systèmes’

Poxel Announces its Participation at Patient Association Conferences in Adrenoleukodystrophy: https://mms.businesswire.com/media/20210929005940/en/578635/5/POXEL_LOGO_Q.jpg
Poxel Announces its Participation at Patient Association Conferences in Adrenoleukodystrophy


Regulatory News:



POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic

Dassault Systèmes Strengthens Its Business Experience for Finance Offering by Integrating the Innova Regtech Solution: https://mms.businesswire.com/media/20191104005004/en/734381/5/3DS_Corp_Logotype_Blue_RGB.jpg
Dassault Systèmes Strengthens Its Business Experience for Finance Offering by Integrating the Innova Regtech Solution


Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) (Paris:DSY) today announced that it has reinforced the Business Experience for Finance offering of OUTSCALE, its leading cloud brand and

Dassault Systèmes to Showcase Sustainable Innovation with the 3DEXPERIENCE Platform at the Paris Air Show 2023: https://mms.businesswire.com/media/20191104005004/en/734381/5/3DS_Corp_Logotype_Blue_RGB.jpg
Dassault Systèmes to Showcase Sustainable Innovation with the 3DEXPERIENCE Platform at the Paris Air Show 2023


Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) (Paris:DSY) today announced a full program of demonstrations and discussions at the Paris Air Show June 19-25, 2023 that will showcase how

RALLYE S.A.: Rallye announces a change in its Executive Management
RALLYE S.A.: Rallye announces a change in its Executive Management
RALLYE S.A.: Rallye announces a change in its Executive Management
EQS-News: Abivax stock included in MSCI Indexes
EQS-News: Abivax stock included in MSCI Indexes
EQS-News: Abivax stock included in MSCI Indexes
RUBIS: Minutes of the Combined Shareholders’ Meeting of 8 June 2023
RUBIS: Minutes of the Combined Shareholders’ Meeting of 8 June 2023
RUBIS: Minutes of the Combined Shareholders’ Meeting of 8 June 2023
EQS-News: Abivax releases the results of its June 5, 2023 ordinary and extraordinary general meeting
EQS-News: Abivax releases the results of its June 5, 2023 ordinary and extraordinary general meeting
EQS-News: Abivax releases the results of its June 5, 2023 ordinary and extraordinary general meeting
EQS-News: Abivax appoints Ida Hatoum as Chief People Officer
EQS-News: Abivax appoints Ida Hatoum as Chief People Officer
EQS-News: Abivax appoints Ida Hatoum as Chief People Officer
Carbios strebt nach einer Führungsposition im wachsenden r-PET-Markt mit dem Ziel, durch ein Lizenzierungsmodell einen Anteil von 8 bis 12 % bis 2035 zu erreichen: https://mms.businesswire.com/media/20191202005614/en/743643/5/LOGO-CARBIOS_Q.jpg
Carbios strebt nach einer Führungsposition im wachsenden r-PET-Markt mit dem Ziel, durch ein Lizenzierungsmodell einen Anteil von 8 bis 12 % bis 2035 zu erreichen


Carbios (Euronext Growth Paris: ALCRB), ein Biotech-Unternehmen, das in der Entwicklung und Industrialisierung von biologischen Technologien zur Neuerfindung des Lebenszyklus von Kunststoffen und

Sensorion to Host Key Opinion Leader Webinar on July 5, 2023; Confirms Upcoming Key Milestones: https://mms.businesswire.com/media/20210609005851/en/705797/5/logo-sensorion2.jpg
Sensorion to Host Key Opinion Leader Webinar on July 5, 2023; Confirms Upcoming Key Milestones


Regulatory News:



Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within

Transgene and NEC Present New Data on TG4050, an Individualized Cancer Vaccine, Showing it Induces Specific Immune Responses against Head and Neck Carcinoma at ASCO 2023: https://mms.businesswire.com/media/20191209005543/en/255636/5/logo_TRANSGENE.jpg
Transgene and NEC Present New Data on TG4050, an Individualized Cancer Vaccine, Showing it Induces Specific Immune Responses against Head and Neck Carcinoma at ASCO 2023


Regulatory News:



Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and NEC Corporation (NEC; TSE: 6701), a

Carbios Aims to be a Leader in Growing r-PET Market with an Ambition to Capture 8 to 12% Share by 2035 Through Licensing Model: https://mms.businesswire.com/media/20191202005614/en/743643/5/LOGO-CARBIOS_Q.jpg
Carbios Aims to be a Leader in Growing r-PET Market with an Ambition to Capture 8 to 12% Share by 2035 Through Licensing Model


Regulatory News:



Carbios (Euronext Growth Paris: ALCRB), a biotech company pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and

Novo Nordisk beginnt exklusive Verhandlungen über den Erwerb einer Mehrheitsbeteiligung an BIOCORP, der ein Kaufangebot für alle verbleibenden Aktien folgen soll: https://mms.businesswire.com/media/20191211005828/en/639213/5/Logo_Biocorp.jpg
Novo Nordisk beginnt exklusive Verhandlungen über den Erwerb einer Mehrheitsbeteiligung an BIOCORP, der ein Kaufangebot für alle verbleibenden Aktien folgen soll


Regulatory News:



Novo Nordisk A/S und BIOCORP Production SA (Paris:ALCOR) meldeten heute, dass Novo Nordisk exklusive Verhandlungen über eine Mehrheitsbeteiligung an BIOCORP aufgenommen hat

Teleperformance Helps Clients Accelerate Business Value From Their Cloud Transformations With Two Amazon Web Services Distinctions: https://mms.businesswire.com/media/20191104005672/en/676465/5/logo_-_new.jpg
Teleperformance Helps Clients Accelerate Business Value From Their Cloud Transformations With Two Amazon Web Services Distinctions


Regulatory News:



Teleperformance (Paris:TEP), a global leader in digital business services, announced today that it achieved Amazon Web Services (AWS) Advanced Tier Services Partner status